A detailed history of Aqr Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aqr Capital Management LLC holds 677,637 shares of LLY stock, worth $520 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
677,637
Previous 474,552 42.8%
Holding current value
$520 Million
Previous $430 Million 39.73%
% of portfolio
0.84%
Previous 0.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $157 Million - $195 Million
203,085 Added 42.8%
677,637 $600 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $50.8 Million - $63.7 Million
70,122 Added 17.34%
474,552 $430 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $40.6 Million - $54.3 Million
68,495 Added 20.39%
404,430 $315 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $15.9 Million - $18.8 Million
30,302 Added 9.91%
335,935 $196 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $629,445 - $867,786
1,448 Added 0.48%
305,633 $164 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $9.47 Million - $12.7 Million
-27,007 Reduced 8.15%
304,185 $143 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $14 Million - $16.5 Million
-45,133 Reduced 11.99%
331,192 $114 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $34.3 Million - $40 Million
-106,760 Reduced 22.1%
376,325 $138 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $16.4 Million - $18.7 Million
-55,251 Reduced 10.26%
483,085 $156 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $92.5 Million - $109 Million
-331,785 Reduced 38.13%
538,336 $174 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $25.2 Million - $31.3 Million
-107,175 Reduced 10.97%
870,121 $249 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $17.5 Million - $21.7 Million
77,648 Added 8.63%
977,296 $270 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $11.9 Million - $14.6 Million
-53,712 Reduced 5.63%
899,648 $208 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $21.2 Million - $27.4 Million
-117,454 Reduced 10.97%
953,360 $219 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $60.7 Million - $78.6 Million
-369,380 Reduced 25.65%
1,070,814 $199 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $8.71 Million - $11.5 Million
-66,733 Reduced 4.43%
1,440,194 $240 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $24.8 Million - $28.7 Million
169,421 Added 12.67%
1,506,927 $220 Million
Q2 2020

Aug 17, 2020

SELL
$136.42 - $164.18 $17.9 Million - $21.6 Million
-131,280 Reduced 8.94%
1,337,506 $218 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $125 Million - $155 Million
-1,050,210 Reduced 41.69%
1,468,786 $199 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $39.5 Million - $49 Million
-369,787 Reduced 12.8%
2,518,996 $329 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $155 Million - $168 Million
-1,446,919 Reduced 33.37%
2,888,783 $323 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $167 Million - $195 Million
1,507,050 Added 53.28%
4,335,702 $480 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $87.1 Million - $102 Million
-782,294 Reduced 21.66%
2,828,652 $366 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $169 Million - $189 Million
1,592,261 Added 78.88%
3,610,946 $418 Million
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $81.7 Million - $102 Million
951,817 Added 89.22%
2,018,685 $217 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $48.3 Million - $55.4 Million
-637,563 Reduced 37.41%
1,066,868 $91 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $25.7 Million - $30.4 Million
-346,580 Reduced 16.9%
1,704,431 $132 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $13 Million - $14 Million
158,755 Added 8.39%
2,051,011 $173 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $146 Million - $162 Million
1,892,256
1,892,256 $162 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.